Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Plos One
|
June 1, 2013
Synergistic inhibition of survival, proliferation, and migration of U87 cells with a combination of LY341495 and Iressa
Zarina Yelskaya, Vangie Carrillo, Ewa Dubisz, et al.
European Journal of Human Genetics : EJHG
|
February 23, 2021
Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) Variant
Zarina Yelskaya, Angela G Arnold, Vanessa J Marcell, et al.
European Journal of Human Genetics : EJHG
|
April 28, 2021
Correction to: Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) variant
Zarina Yelskaya, Angela G Arnold, Vanessa J Marcell, et al.
NPJ Precision Oncology
|
June 8, 2026
Independent somatic TP53 mutations in blood and tumor mimicking Li-Fraumeni syndrome in a 94-year-old man
Chuan Gao, Vikas Rai, Donna Wong, et al.
Plos One
|
November 24, 2016
CDH1 Missense Variant c.1679C>G (p.T560R) Completely Disrupts Normal Splicing through Creation of a Novel 5' Splice Site
Zarina Yelskaya, Ruben Bacares, Erin Salo-Mullen, et al.
Plos One
|
February 24, 2017
Osteosarcoma cell proliferation and survival requires mGluR5 receptor activity and is blocked by Riluzole
Sally Liao, Yuleisy Ruiz, Hira Gulzar, et al.
JAMA Oncology
|
June 7, 2018
Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors
Ryan N Ptashkin, Diana L Mandelker, Catherine C Coombs, et al.
BMC Medical Genomics
|
May 21, 2017
Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing
Donavan T Cheng, Meera Prasad, Yvonne Chekaluk, et al.
NPJ Precision Oncology
|
January 2, 2023
Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations
Diana Mandelker, Antonio Marra, Nikita Mehta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 22, 2023
Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma
Diana Mandelker, Antonio Marra, Binbin Zheng-Lin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Plos One
|
June 1, 2013
Synergistic inhibition of survival, proliferation, and migration of U87 cells with a combination of LY341495 and Iressa
Zarina Yelskaya, Vangie Carrillo, Ewa Dubisz, et al.
European Journal of Human Genetics : EJHG
|
February 23, 2021
Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) Variant
Zarina Yelskaya, Angela G Arnold, Vanessa J Marcell, et al.
European Journal of Human Genetics : EJHG
|
April 28, 2021
Correction to: Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) variant
Zarina Yelskaya, Angela G Arnold, Vanessa J Marcell, et al.
NPJ Precision Oncology
|
June 8, 2026
Independent somatic TP53 mutations in blood and tumor mimicking Li-Fraumeni syndrome in a 94-year-old man
Chuan Gao, Vikas Rai, Donna Wong, et al.
Plos One
|
November 24, 2016
CDH1 Missense Variant c.1679C>G (p.T560R) Completely Disrupts Normal Splicing through Creation of a Novel 5' Splice Site
Zarina Yelskaya, Ruben Bacares, Erin Salo-Mullen, et al.
Plos One
|
February 24, 2017
Osteosarcoma cell proliferation and survival requires mGluR5 receptor activity and is blocked by Riluzole
Sally Liao, Yuleisy Ruiz, Hira Gulzar, et al.
JAMA Oncology
|
June 7, 2018
Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors
Ryan N Ptashkin, Diana L Mandelker, Catherine C Coombs, et al.
BMC Medical Genomics
|
May 21, 2017
Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing
Donavan T Cheng, Meera Prasad, Yvonne Chekaluk, et al.
NPJ Precision Oncology
|
January 2, 2023
Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations
Diana Mandelker, Antonio Marra, Nikita Mehta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 22, 2023
Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma
Diana Mandelker, Antonio Marra, Binbin Zheng-Lin, et al.
Page
of 2